Kris Vedder

Kris Vedder has extensive work experience in the healthcare and pharmaceutical industries. Kris is currently working at GRAIL as an Associate Director, Lab Commercial Partnerships since June 2022. Prior to that, they worked at BillionToOne as a Director of Business Development from June 2021 to June 2022. From 2014 to 2021, Kris served as the Director of Strategic Accounts at Progenity, where they managed care, strategic partnerships, and was responsible for sales in areas such as NIPT, Genetic Screening, IVF, and Oncology. During their time at Progenity, they achieved multiple Chairman's Club Awards. Before joining Progenity, Kris worked at QIAGEN as a Women's Health Specialist from 2009 to 2014, where they received several awards for their sales performance. Kris started their career at KV Pharmaceutical as a Senior Specialty Representative from 2004 to 2009, and at Daiichi Sankyo, Inc. as a Pharmaceutical Sales Professional II/Cardiology Specialist from 2001 to 2004, where they received awards for their sales achievements.

Kris Vedder earned a Bachelor's Degree in Business from the College of Business and Economics at Washington State University. The duration of this program was not indicated, and no other educational experiences were provided.